Comparative effects of sibutramine and orlistat on weight loss, glucose metabolism and leptin levels in non-diabetic obese patients: A prospective study
Main Authors: | Panagiotis Anagnostis, Despina Selalmatzidou, Michalis Sapranidis, Athanasios Panagiotou, Stergios A Polyzos, Aristidis Slavakis, Marina Kita |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2012-01-01
|
Series: | Indian Journal of Endocrinology and Metabolism |
Online Access: | http://www.ijem.in/article.asp?issn=2230-8210;year=2012;volume=16;issue=1;spage=146;epage=147;aulast=Anagnostis |
Similar Items
-
Efficacy and Tolerability of the Association of Sibutramine and
Orlistat for Six Months in Overweight and Obese Patients
by: Alfredo Halpern, et al.
Published: (2010-01-01) -
A survey on clinical effectiveness of orlistat compared to sibutramine, lorcaserin, metformin and placebo on weight loss in obese people: a network meta-analysis
by: Somaye Fatahi, et al.
Published: (2018-09-01) -
Effect of two days treatment with orlistat on plasma leptin in obese patients without weight loss
by: Ana Rodríguez-Valle, et al. -
Combination of the sodium-glucose cotransporter-2 inhibitor empagliflozin with orlistat or sibutramine further improves the body-weight reduction and glucose homeostasis of obese rats fed a cafeteria diet
by: Vickers SP, et al.
Published: (2014-07-01) -
Obesity management: Update on orlistat
by: Belinda S Drew, et al.
Published: (2008-01-01)